Aardvark Therapeutics logo
Aardvark Therapeutics logo

Aardvark Therapeutics

aardvarktherapeutics.com
aardvarktherapeutics.com • HQ: San Diego, United States • Venture - Series Unknown 2024 • 201-500 employees • Founded 2017 • NASDAQ: AARD
HQ: San Diego, United States • Venture - Series Unknown 2024 • 201-500 employees • Founded 2017 • NASDAQ: AARD
Biologics & Biosimilars
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Visa sponsorship

  • United States · H-1B filings in 12 months: 1

Visa details by country

Overview

Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic.

People

Tien-Li Lee
Executive Officer, Director
SEC Form D
Nelson Sun
Executive Officer
SEC Form D
Bob Shin
Director
SEC Form D
Jeffrey Chi
Director
SEC Form D
Zachary Hornby
Director
SEC Form D
Jerel Banks
Director
SEC Form D
Henry Ji
Director
SEC Form D
Victor Tong
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego United States
HQ
Contact Us
200-500 est. staff
Suite 1050,, San Diego, CA 92122
company site

Financials

Total raised
$103.1M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $85M Details
Venture - Series Unknown 2021 $9.1M Details
Venture - Series Unknown 2019 $9M Details